Navigation Links
S1 Biopharma Doses First Patients in Phase 2a Clinical Trial of Lorexys in Premenopausal Women with HSDD
Date:7/29/2013

JERSEY CITY, N.J., July 29, 2013 /PRNewswire/ -- S1 Biopharma, Inc., a developer of first-in-class drugs for sexual dysfunction in women and men, today announced enrollment and dosing of premenopausal women with hypoactive sexual desire disorder (HSDD) in the Phase 2a clinical trial of its leading drug candidate Lorexys (S1P-104).  

"The initiation of this study marks a significant milestone for S1 Biopharma as we advance Lorexys' clinical development," said Nicolas G. Sitchon, chief executive officer of S1 Biopharma. "Despite significant effort over many years, there are no FDA-approved treatments for women with HSDD. We believe Lorexys may provide the first safe and effective treatment option for those whose lives and the lives of their partners are affected by the disorder. By restoring the balance of the key neurotransmitters that regulate sexual desire in the brain we expect that Lorexys will help women with sexual desire and arousal disorders regain a healthy sexual life."

The leading scientific model of the regulation of sexual desire in the brain is the Kinsey dual control model. It explains that sexual inhibition and sexual excitation are kept in balance by activating and inhibiting neurotransmitters including serotonin, norepinephrine and dopamine.

"Lorexys, which is a first-in-class drug for HSDD, was formulated by identifying the two psychiatric medications, bupropion and trazodone, that, when combined in a precise, proprietary ratio, would modulate the activity of these neurotransmitters, neutralize the monoamine modulators' side effects and maximize beneficial effects on sexual function," said Robert E. Pyke, M.D., Ph.D., chief medical officer of S1 Biopharma. "Pilot data supported positive effects, unlike other serotonergic agents or combinations studied in our early drug development. S1P-205,
'/>"/>

SOURCE S1 Biopharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
2. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
3. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
4. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
5. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
6. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
7. S1 Biopharma Expands Focus to Include Male Sexual Health
8. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
9. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
10. Cell Therapeutics Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs
11. Galena Biopharma, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 2014 Ambit Biosciences (Nasdaq: AMBI ), a ... unmet needs in oncology, autoimmune and inflammatory disease, today announced ... to be held at The New York Palace Hotel in ... 2014. Alan Fuhrman , Ambit,s CFO, will ... candidate, quizartinib, at 1:10 p.m. ET on Wednesday, September 3, ...
(Date:8/27/2014)... Pa. , Aug. 27, 2014   Auxilium Pharmaceuticals ... integrated specialty biopharmaceutical company, today announced that certain members ... Morgan Stanley Healthcare Conference to be held September 8-10, ... Adrian Adams , Chief Executive Officer and President, is ... its product portfolio at 10:55 a.m. ET on Wednesday, ...
(Date:8/26/2014)... , Aug. 27, 2014 Higher ... insurance are fuelling the demand for medical devices ... rise of medical tourism, the inflow of patients ... The market will continue its steady ascent as ... age-related and non-communicable diseases, compelling significant investments in ...
Breaking Medicine Technology:Ambit Announces Participation At Baird 2014 Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference 3Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market 2Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market 3Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market 4
(Date:8/27/2014)... 27, 2014 Lighthouse Payment Services ... announced that it will exhibit its image-based lockbox services ... 41st annual convention in beautiful Lake Placid, New ... event will be held at the Lake Placid Convention ... and entertainment options in addition to a variety of ...
(Date:8/27/2014)... 2014 Aspirus Wausau Hospital today announced ... with Buzz™ Digital O.R. at Aspirus Wausau Hospital, in ... new operating rooms will be Buzz, a centralized surgical ... system supports planning, navigation, imaging and communications connectivity. ... intuitive software and hardware all controlled from the full ...
(Date:8/27/2014)... Health care workers in poor nations often do not ... being infected with blood-borne viruses such as Ebola and ... was conducted before the current Ebola outbreak began in ... statistics released Monday by the World Health Organization (WHO). ... number of health care workers have lost their lives ...
(Date:8/27/2014)... Stroke patients are 70 per cent more likely to ... if they have a prescription in hand when discharged ... and the Institute for Clinical Evaluative Sciences (ICES). , ... many Ontarians were taking their medications one week, one ... results reveal the importance of simple interventions, such as ...
(Date:8/27/2014)... Chino Hills, CA (PRWEB) August 27, 2014 ... boot camp franchise in the world, the leading fitness ... to Spike TV’s Gym Rescue reality series. One thing he ... personal brand as a subject matter expert in the fitness ... uploaded to YouTube, he lays out a step-by-step instructional guide ...
Breaking Medicine News(10 mins):Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 3Health News:Lack of Protective Gear Leaves Medics at Risk in Ebola Outbreak: Study 2Health News:Lack of Protective Gear Leaves Medics at Risk in Ebola Outbreak: Study 3Health News:A prescription for better stroke care 2Health News:Bedros Keuilian Releases New Fitness Boot Camp Marketing Webinar on Building a Personal Brand 2Health News:Bedros Keuilian Releases New Fitness Boot Camp Marketing Webinar on Building a Personal Brand 3
... , ... Fresh Look at Coping with Multiple Sclerosis through Community , ... (PRWEB) April 13, 2010 -- Motivational Speaker/MS ... guidebook for those newly diagnosed with Multiple Sclerosis. , , ,Published by iUniverse ...
... likely to develop, die from disease , TUESDAY, April 13 ... comes to both developing and dying from lung cancer. , ... grim picture of how environmental factors, biological factors, cultural attitudes ... deadly disease even deadlier among members of this minority group. ...
... ... patients and may be covered by medical insurance will be provided by Khanna institute in ... (Vocus) April ... with countless solutions for eye and sight problems, hereby announces that it is offering its ...
... mutated gene in human cancers is the reitnoblastoma (RB) gene, ... gene disable the vast and intricate RB pathway in virtually ... cellular functions and ultimately provoking cancer. But which of these ... uncertain. "We have now found that a key function ...
... ... general availability of ActiveStrategy iRound™, which enables field-level performance management data to be ... Enterprise software. , ... (PRWEB) April 13, 2010 -- ActiveStrategy, the leading provider of comprehensive ...
... on failure rates could aid surgeons who import donor tissue, ... a corneal transplant will fail is not affected by the ... transplanted cornea was preserved or the method of preservation, according ... study that included 388 people who were followed for up ...
Cached Medicine News:Health News:Author Erin Morrow Still Releases "Fighting MS: Strength in Numbers" 2Health News:Author Erin Morrow Still Releases "Fighting MS: Strength in Numbers" 3Health News:Blacks Hit Hardest by Lung Cancer 2Health News:Blacks Hit Hardest by Lung Cancer 3Health News:Khanna Institute to Provide Intacs Corneal Implants in Beverly Hills 2Health News:Khanna Institute to Provide Intacs Corneal Implants in Beverly Hills 3Health News:CSHL scientists discover how a tumor suppressor induces senescence and staves off cancer 2Health News:ActiveStrategy iRound™ is Launched to Enable Seamless Capture of Field-Level Performance Management Data 2Health News:ActiveStrategy iRound™ is Launched to Enable Seamless Capture of Field-Level Performance Management Data 3Health News:Corneal Transplant Not Hurt by Long Preservation Time 2
... Antibody (IgM) Test is an ... quantitative detection of antibodies to ... is used as an aid ... thrombosis in individuals with systemic ...
The 8500 is an extremely reliable portable pulse oximeter, requiring no periodic maintenance or calibration....
Rad-5v signal extraction pulse oximeter™...
... The 8500 Digital Handheld ... universal tool for patients monitoring ... continuous monitoring. As the first ... as a benchmark for durability ...
Medicine Products: